Stay updated on SB17 vs Stelara in Plaque Psoriasis Clinical Trial
Sign up to get notified when there's something new on the SB17 vs Stelara in Plaque Psoriasis Clinical Trial page.

Latest updates to the SB17 vs Stelara in Plaque Psoriasis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page version was updated from v3.0.2 to v3.2.0, indicating a software/content update. No other content changes were detected.SummaryDifference0.1%
- Check17 days agoChange DetectedVersion bumped from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%
- Check31 days agoChange DetectedVersion updated to v3.0.2; the only changes are the new revision tag and removal of the 'Back to Top' link. No substantive changes to core content, pricing, stock, or time slots.SummaryDifference0.3%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.3%
- Check46 days agoChange DetectedThe web page has updated the list of study locations, reducing the total from 33 to 32, and has added specific names of locations in South Korea, Poland, the Czech Republic, and Ukraine, while also introducing new scientific terms related to blood proteins and antibodies.SummaryDifference7%
- Check60 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to SB17 vs Stelara in Plaque Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SB17 vs Stelara in Plaque Psoriasis Clinical Trial page.